Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 31, 2020 - Issue 8
Submit an article Journal homepage
419
Views
8
CrossRef citations to date
0
Altmetric
Psoriasis

Sustained and continuously improved efficacy of tildrakizumab in patients with moderate-to-severe plaque psoriasis

Boni ElewskiDepartment of Dermatology, University of Alabama at Birmingham, Birmingham, AL, USA; Correspondence[email protected]
View further author information
,
Alan MenterDivision of Dermatology, Baylor Scott & White, Dallas, TX, USA; ORCID Iconhttp://orcid.org/0000-0002-9314-0007View further author information
ORCID Icon,
Jeffrey CrowleyBakersfield Dermatology, Bakersfield, CA, USA; View further author information
,
Stephen TyringDepartment of Dermatology, University of Texas Health Science Center, Houston, TX, USA; View further author information
,
Yang ZhaoSun Pharmaceuticals, Princeton, NJ, USA; View further author information
,
Simon LowrySun Pharmaceuticals, Princeton, NJ, USA; View further author information
,
Stephen RozzoSun Pharmaceuticals, Princeton, NJ, USA; View further author information
,
Alan M. MendelsohnSun Pharmaceuticals, Princeton, NJ, USA; View further author information
,
Jeffrey ParnoSun Pharmaceuticals, Princeton, NJ, USA; View further author information
&
Kenneth GordonMedical College of Wisconsin, Milwaukee, WI, USAView further author information
 show all
Pages 763-768 | Received 07 Jun 2019, Accepted 17 Jun 2019, Published online: 22 Jul 2019

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Isabel Belinchón Romero, Esteban Dauden, Carlos Ferrándiz Foraster, Álvaro González-Cantero & Jose Manuel Carrascosa Carrillo. (2022) PASI 100 response rates in moderate to severe psoriasis: a systematic literature review and analysis of clinical practice guidelines. Journal of Dermatological Treatment 33:3, pages 1661-1669.
Read now

Articles from other publishers (7)

Alessio Gambardella, Gaetano Licata, Alina De Rosa, Giulia Calabrese, Roberto Alfano & Giuseppe Argenziano. (2022) Treatment of moderate‐to‐severe plaque psoriasis with tildrakizumab in the real‐life setting. JEADV Clinical Practice 2:1, pages 52-58.
Crossref
Angelo Ruggiero, Matteo Megna, Gabriella Fabbrocini & Sonia Sofia Ocampo-Garza. (2023) Anti-IL23 biologic therapies in the treatment of psoriasis: real-world experience versus clinical trials data. Immunologic Research.
Crossref
Athanasios Tsianakas, Uwe Schwichtenberg, Peter Pierchalla, Torsten Hinz, Sebastian Diemert & Bernhard Korge. (2022) Real‐world effectiveness and safety of tildrakizumab in long‐term treatment of plaque psoriasis: Results from the non‐interventional, prospective, multicentre study TILOT . Journal of the European Academy of Dermatology and Venereology 37:1, pages 85-92.
Crossref
Marco Galluzzo, Marina Talamonti, Arnaldo Cioni, Virginia Maffei, Ruslana Gaeta Shumak, Lorenzo Tofani, Luca Bianchi & Elena Campione. (2022) Efficacy of Tildrakizumab for the Treatment of Difficult-to-Treat Areas: Scalp, Nail, Palmoplantar and Genital Psoriasis. Journal of Clinical Medicine 11:9, pages 2631.
Crossref
J.M. Carrascosa, L. Puig, I. Belinchón Romero, L. Salgado-Boquete, E. del Alcázar, J.J. Andrés Lencina, D. Moreno & P. de la Cueva. (2022) [Translated article] Practical Update of the Recommendations Published by the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (GPs) on the Treatment of Psoriasis with Biologic Therapy. Part 1. Concepts and General Management of Psoriasis With Biologic Therapy. Actas Dermo-Sifiliográficas 113:3, pages T261-T277.
Crossref
J.M. Carrascosa, L. Puig, I. Belinchón Romero, L. Salgado-Boquete, E. del Alcázar, J.J. Andrés Lencina, D. Moreno & P. de la Cueva. (2022) Actualización práctica de las recomendaciones del Grupo de Psoriasis de la Academia Española de Dermatología y Venereología (GPS) para el tratamiento de la psoriasis con terapia biológica. Parte 1. «Conceptos y manejo general de la psoriasis con terapia biológica». Actas Dermo-Sifiliográficas 113:3, pages 261-277.
Crossref
Feras M. Ghazawi, Farhan Mahmood, Leon Kircik, Yves Poulin, Marc Bourcier, Ronald Vender, Marni C. Wiseman, Charles Lynde & Ivan V. Litvinov. (2021) A Review of the Efficacy and Safety for Biologic Agents Targeting IL-23 in Treating Psoriasis With the Focus on Tildrakizumab. Frontiers in Medicine 8.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.